IS5220A - Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum - Google Patents

Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Info

Publication number
IS5220A
IS5220A IS5220A IS5220A IS5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A
Authority
IS
Iceland
Prior art keywords
carprofen
oxygenase
cyclo
dogs
inflammation
Prior art date
Application number
IS5220A
Other languages
English (en)
Icelandic (is)
Inventor
Marie Lundy Kristin
Paul Ricketts Anthony
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5220A publication Critical patent/IS5220A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IS5220A 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum IS5220A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (fr) 1997-05-05 1998-05-01 Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens

Publications (1)

Publication Number Publication Date
IS5220A true IS5220A (is) 1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5220A IS5220A (is) 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
WO2000053149A2 (fr) * 1999-03-10 2000-09-14 G.D. Searle & Co. Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
RU2003100874A (ru) 2000-06-13 2004-06-27 Вайс (Us) Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
US7189504B2 (en) 2000-08-07 2007-03-13 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
CA2519189C (fr) 2003-05-07 2012-07-17 Osteologix A/S Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os
KR100780983B1 (ko) * 2003-07-31 2007-11-30 파마시아 앤드 업존 캄파니 엘엘씨 소염제의 분산성 제제
WO2006123247A2 (fr) * 2005-05-20 2006-11-23 Pfizer Limited Combinaisons synergiques
WO2008122967A2 (fr) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Composition pharmaceutique orale
WO2008132707A1 (fr) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Fabrication de minicapsules multiples
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (fr) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
DK3113774T3 (da) 2014-03-06 2022-03-07 Elanco Animal Health Incorporated Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
MX2017009011A (es) * 2015-01-09 2017-10-02 Jaguar Animal Health Metodos para tratar la diarrea en animales de compañia.
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
SK148199A3 (en) 2001-09-11
HRP980244A2 (en) 1999-02-28
JP2000513020A (ja) 2000-10-03
YU55899A (sh) 2003-08-29
HUP0001286A3 (en) 2000-12-28
KR20040004406A (ko) 2004-01-13
EA003696B1 (ru) 2003-08-28
AR039628A2 (es) 2005-03-02
BR9808720A (pt) 2000-07-11
PE72599A1 (es) 1999-08-12
NZ500183A (en) 2002-04-26
UY24989A1 (es) 2001-10-25
TNSN98059A1 (fr) 2005-03-15
CA2288759A1 (fr) 1998-11-12
KR20010012300A (ko) 2001-02-15
EP0988034A1 (fr) 2000-03-29
AR011726A1 (es) 2000-08-30
HUP0001286A2 (hu) 2000-11-28
IL132570A0 (en) 2001-03-19
ZA983722B (en) 1999-11-04
EA199900895A1 (ru) 2000-06-26
GT199800063A (es) 1999-10-26
WO1998050033A1 (fr) 1998-11-12
AU6932198A (en) 1998-11-27
OA11213A (en) 2003-07-14
PA8450601A1 (es) 2000-05-24
PL337003A1 (en) 2000-07-31
DZ2479A1 (fr) 2003-02-01
AP9801234A0 (en) 1999-11-04
TW590773B (en) 2004-06-11
NO995389D0 (no) 1999-11-04
MA26491A1 (fr) 2004-12-20
ID21311A (id) 1999-05-20
BG103852A (en) 2000-06-30
CN1255059A (zh) 2000-05-31
NO995389L (no) 2000-01-04

Similar Documents

Publication Publication Date Title
IS5220A (is) Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DE69825447D1 (de) Gerät zur dermatologischen behandlung
IS2107B (is) Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
IS5921A (is) Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
BR0015012B1 (pt) aparelho para exercÍcios aumentados e alÍvio de dores nas costas.
NO20004544L (no) Forbedret pumpeanordning og forbedrede fremgangsmÕter
ID18741A (id) Zat nikotinat dalam terapi
DE60019490D1 (de) Brennstofförder-und behandlungsvorrichtung
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
DE69701250D1 (de) Tierbehandlungsvorrichtung
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
IS5809A (is) Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar
NO326826B1 (no) Alfa-aminosyreamider, fremstilling og terapeutisk anvendelse derav
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka